L-Glutamic acid,N-[4-[[(2,4-diamino-7,8-dihydro-7-oxo-6-pteridinyl)methyl]methylamino]benzoyl]- cas no:5939-37-7
Synonyms: Glutamicacid, N-[p-[[(2,4-diamino-7-hydroxy-6-pteridinyl)methyl]methylamino]benzoyl]-(7CI); Glutamic acid,N-[p-[[(2,4-diamino-7-hydroxy-6-pteridinyl)methyl]methylamino]benzoyl]-, L-(+)-(8CI); L-Glutamic acid,N-[4-[[(2,4-diamino-1,7-dihydro-7-oxo-6-pteridinyl)methyl]methylamino]benzoyl]-(9CI); 7-Hydroxymethotrexate; NSC 380962
NameL-Glutamic acid,N-[4-[[(2,4-diamino-7,8-dihydro-7-oxo-6-pteridinyl)methyl]methylamino]benzoyl]-
CAS5939-37-7
SynonymsGlutamicacid, N-[p-[[(2,4-diamino-7-hydroxy-6-pteridinyl)methyl]methylamino]benzoyl]-(7CI); Glutamic acid,N-[p-[[(2,4-diamino-7-hydroxy-6-pteridinyl)methyl]methylamino]benzoyl]-, L-(+)-(8CI); L-Glutamic acid,N-[4-[[(2,4-diamino-1,7-dihydro-7-oxo-6-pteridinyl)methyl]methylamino]benzoyl]-(9CI); 7-Hydroxymethotrexate; NSC 380962
Molecular FormulaC20H22 N8 O6
Molecular Weight470.50
refractive index1.76
storage temp−20°C
Safety
A poison by intravenous route. When heated to decomposition it emits toxic vapors of NOx.
| Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
| rat |
LD50 |
intravenous |
300mg/kg (300mg/kg) |
|
Cancer Chemotherapy and Pharmacology. Vol. 37, Pg. 415, 1996. |
